Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Trotter

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Gastroenterology|September 11, 1998
Hereditary hemorrhagic telangiectasia causing high output cardiac failure: treatment with transcatheter embolizationJ F Trotter, P V Suhocki, J R Lina, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 15, 2013
Predicting end-stage renal disease after liver transplantA K Israni, H Xiong, J Liu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 10, 2001
Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of lifeJ F Trotter, M Talamantes, M McClure, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2014
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trialS K Asrani, R H Wiesner, J F Trotter, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 5, 2011
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppressionG J McKenna, J F Trotter, E Klintmalm, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2008
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort StudyC E Freise, B W Gillespie, A J Koffron, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2010
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant RegistryB W Gillespie, R M Merion, E Ortiz-Rios, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2017
The Living Donor Collective: A Scientific Registry for Living DonorsB L Kasiske, S K Asrani, M A Dew, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Gastroenterology|September 11, 1998
Hereditary hemorrhagic telangiectasia causing high output cardiac failure: treatment with transcatheter embolizationJ F Trotter, P V Suhocki, J R Lina, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 15, 2013
Predicting end-stage renal disease after liver transplantA K Israni, H Xiong, J Liu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 10, 2001
Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of lifeJ F Trotter, M Talamantes, M McClure, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2014
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trialS K Asrani, R H Wiesner, J F Trotter, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 5, 2011
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppressionG J McKenna, J F Trotter, E Klintmalm, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2008
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort StudyC E Freise, B W Gillespie, A J Koffron, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2010
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant RegistryB W Gillespie, R M Merion, E Ortiz-Rios, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2017
The Living Donor Collective: A Scientific Registry for Living DonorsB L Kasiske, S K Asrani, M A Dew, et al.
Pageof 4